Enlivex Therapeutics Ltd. Announces Date for Extraordinary General Meeting of Shareholders
I'm PortAI, I can summarize articles.
Enlivex Therapeutics Ltd. will hold an Extraordinary General Meeting of Shareholders on February 3, 2026, in Ness Ziona, Israel. Shareholders will vote on key proposals, including amendments to the Articles of Association, changing the company name, classifying the Board of Directors, increasing authorized share capital, and approving amendments to the exemption and indemnification agreement for directors and the CEO, as well as an equity bonus for the CEO.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments